| Primary |
| Enuresis |
19.8% |
| Diabetes Insipidus |
18.8% |
| Nocturia |
12.4% |
| Hypopituitarism |
9.9% |
| Product Used For Unknown Indication |
8.4% |
| Urinary Incontinence |
5.0% |
| Depression |
4.5% |
| Anxiety |
3.0% |
| Haemorrhage Prophylaxis |
3.0% |
| Osteoporosis |
2.5% |
| Hypertonic Bladder |
2.0% |
| Hypophysectomy |
2.0% |
| Hypertension |
1.5% |
| Prophylaxis |
1.5% |
| Atrial Fibrillation |
1.0% |
| Diabetes Mellitus |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
| Micturition Urgency |
1.0% |
| Stress Urinary Incontinence |
1.0% |
| Turner's Syndrome |
1.0% |
|
| Hyponatraemia |
20.4% |
| Water Intoxication |
10.2% |
| Vomiting |
7.4% |
| Convulsion |
6.5% |
| Off Label Use |
5.6% |
| Extrasystoles |
4.6% |
| Hypernatraemia |
4.6% |
| Loss Of Consciousness |
4.6% |
| Palpitations |
4.6% |
| Somnolence |
4.6% |
| Inappropriate Antidiuretic Hormone Secretion |
3.7% |
| Vena Cava Thrombosis |
3.7% |
| Vertigo |
3.7% |
| Nausea |
2.8% |
| Urinary Tract Infection |
2.8% |
| Visual Acuity Reduced |
2.8% |
| Blood Pressure Systolic Increased |
1.9% |
| Chest Pain |
1.9% |
| Condition Aggravated |
1.9% |
| Delirium |
1.9% |
|
| Secondary |
| Diabetes Insipidus |
13.6% |
| Type 2 Diabetes Mellitus |
12.6% |
| Product Used For Unknown Indication |
11.7% |
| Congestive Cardiomyopathy |
11.0% |
| Drug Use For Unknown Indication |
8.5% |
| Hypopituitarism |
6.9% |
| Hypertension |
4.4% |
| Hyperuricaemia |
4.4% |
| Hyperkalaemia |
4.1% |
| Hypertriglyceridaemia |
4.1% |
| Enuresis |
3.8% |
| Anxiety |
2.5% |
| Micturition Urgency |
2.2% |
| Blood Follicle Stimulating Hormone Decreased |
1.9% |
| Blood Thyroid Stimulating Hormone Decreased |
1.9% |
| Depression |
1.6% |
| Blood Luteinising Hormone Decreased |
1.3% |
| Osteoporosis |
1.3% |
| Stress Urinary Incontinence |
1.3% |
| Cardiomyopathy |
0.9% |
|
| Hyponatraemia |
21.4% |
| Water Intoxication |
17.1% |
| Bladder Cancer |
8.6% |
| Off Label Use |
5.7% |
| Convulsion |
4.3% |
| Oedema Peripheral |
4.3% |
| Pancreatitis Acute |
4.3% |
| Rhabdomyolysis |
4.3% |
| Asthenia |
2.9% |
| Bladder Transitional Cell Carcinoma Stage Ii |
2.9% |
| Condition Aggravated |
2.9% |
| Hypernatraemia |
2.9% |
| Somnolence |
2.9% |
| Tongue Disorder |
2.9% |
| Urinary Retention |
2.9% |
| Vertigo |
2.9% |
| Vomiting |
2.9% |
| Acute Febrile Neutrophilic Dermatosis |
1.4% |
| Amaurosis Fugax |
1.4% |
| Angioedema |
1.4% |
|
| Concomitant |
| Growth Hormone Deficiency |
12.2% |
| Drug Use For Unknown Indication |
11.1% |
| Hypopituitarism |
10.1% |
| Multiple Sclerosis |
7.1% |
| Product Used For Unknown Indication |
6.9% |
| Diabetes Insipidus |
5.8% |
| Enuresis |
5.0% |
| Primary Hypothyroidism |
4.8% |
| Blood Thyroid Stimulating Hormone Decreased |
4.7% |
| Erectile Dysfunction |
4.5% |
| Hormone Replacement Therapy |
3.7% |
| Blood Follicle Stimulating Hormone Decreased |
3.4% |
| Blood Luteinising Hormone Decreased |
3.4% |
| Blood Antidiuretic Hormone Decreased |
3.2% |
| Blood Corticotrophin Decreased |
3.1% |
| Hypothyroidism |
2.4% |
| Essential Hypertension |
2.3% |
| Anxiety |
2.1% |
| Epilepsy |
2.1% |
| Hypogonadism Female |
2.1% |
|
| Progressive Multifocal Leukoencephalopathy |
17.1% |
| Craniopharyngioma |
11.7% |
| Pituitary Tumour Benign |
9.9% |
| Ovarian Cyst |
7.2% |
| Glioblastoma |
5.4% |
| Epilepsy |
4.5% |
| Syncope |
4.5% |
| Thrombocytopenia |
4.5% |
| Meningitis Herpes |
3.6% |
| Suicide Attempt |
3.6% |
| Vomiting |
3.6% |
| Clear Cell Carcinoma Of The Kidney |
2.7% |
| Furuncle |
2.7% |
| Headache |
2.7% |
| Hyponatraemia |
2.7% |
| Nephrolithiasis |
2.7% |
| Osteonecrosis |
2.7% |
| Rathke's Cleft Cyst |
2.7% |
| Sedation |
2.7% |
| Wrist Fracture |
2.7% |
|
| Interacting |
| Neck Pain |
44.4% |
| Diabetes Insipidus |
33.3% |
| Breast Cancer |
11.1% |
| Spinal Osteoarthritis |
11.1% |
|
| Water Intoxication |
60.0% |
| Drug Interaction |
20.0% |
| Hyponatraemia |
20.0% |
|
